TUESDAY, July 14, 2026 (NewsDay News) — Chronic kidney disease (CKD) is more commonly associated with diabetes, according to a research letter published online July 8.New England Journal of Medicine.
Sophie E. Claudel, MD, of Boston Medical Center, and Ashish Verma, MBBS, of Boston University, reviewed current national trends in the prevalence of CKD. The analysis included data on 25,106 adults (age 20 and older) who participated in four periods of the National Health and Nutrition Examination Survey from 2013-2014 to 2021-2023.
The researchers found that the prevalence of CKD remained stable between 2013-2014 (14.5 percent) and 2021-2023 (14.8 percent), equivalent to an estimated 36 million adults. During the study period, a greater proportion of adults met criteria based on albuminuria alone than low glomerular filtration rate (eGFR) (8.6 vs. 4.1 percent in 2021-2023). There was variation in CKD prevalence by demographic characteristics and comorbidity burden, with greater prevalence among black adults and those living below the federal poverty threshold. Over time, the burden of CHD with diabetes increased from 4.7 percent in 2013–2014 to 5.7 percent in 2021–2023 (prevalence ratio, 1.29), with no change in the prevalence of CHD without diabetes. There was also a strong association between heart failure and the prevalence of CKD, with this association peaking in the period 2021–2023 (adjusted prevalence ratio, 2.47), with obesity (adjusted prevalence ratio, 1.35) and diabetes (adjusted prevalence ratio, 1.35) and diabetes (adjusted prevalence ratio, 249). CKD.
“This is the first CKD study to use data from recently published studies spanning a decade, during which the first treatments for kidney protection, including SGLT2 inhibitors and firenone (a nonsteroidal mineralocorticoid receptor antagonist that reduces the risk of kidney failure), were approved. Rates have remained stagnant,” Verma said in a statement.
Abstract / Full Text (subscription or payment may be required)
